(Q36027278)

English

Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (adriamycin) in doxorubicin-resistant P388 mouse leukaemia cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (adriamycin) in doxorubicin-resistant P388 mouse leukaemia cells (English)

1 reference

Europe PubMed Central

11 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

R Ganapathi

1

1 reference

Europe PubMed Central

11 August 2017

A Yen

2

1 reference

Europe PubMed Central

11 August 2017

D Grabowski

3

1 reference

Europe PubMed Central

11 August 2017

H Schmidt

4

1 reference

Europe PubMed Central

11 August 2017

R Turinic

5

1 reference

Europe PubMed Central

11 August 2017

R Valenzuela

6

1 reference

Europe PubMed Central

11 August 2017

language of work or name

0 references

publication date

1 April 1986

1 reference

Europe PubMed Central

11 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

11 August 2017

53

1 reference

Europe PubMed Central

11 August 2017

561-566

1 reference

Europe PubMed Central

11 August 2017

4

1 reference

Europe PubMed Central

11 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1986.88

0 references

Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of doxorubicin (adriamycin) in resistant P388 mouse leukemia cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001449

2 October 2017

Analysis of heterogeneity in daunorubicin uptake by human leukemia cells using laser flow cytometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001449

2 October 2017

Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001449

2 October 2017

Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001449

2 October 2017

Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001449

27 July 2018

Effect of adriamycin on the cell cycle traverse and kinetics of cultured human lymphoblasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001449

27 July 2018

Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001449

27 July 2018

Membrane alterations associated with progressive adriamycin resistance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001449

23 September 2018

Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001449

23 September 2018

Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001449

23 September 2018

Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001449

23 September 2018

Potentiation of drug effect by Tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001449

23 September 2018

Comparison of the cellular pharmacology of doxorubicin in resistant and sensitive models of pancreatic cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001449

23 September 2018

Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001449

23 September 2018

Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3707847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circumvention of resistance to daunorubicin by N-acetyldaunorubicin in Ehrlich ascites tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/3707847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calmodulin and the cell cycle: involvement in regulation of cell-cycle progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/3707847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell control of B-cell proliferation uncoupled from differentiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/3707847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1986.88

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36027278&oldid=1991275504"